 Taylor Triolo
Concepts (122)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 1 | 13 | 2025 | 3628 | 1.770 |
Why?
| | C-Peptide | 2 | 2025 | 163 | 1.740 |
Why?
| | Islets of Langerhans Transplantation | 2 | 2024 | 63 | 1.570 |
Why?
| | Insulin-Secreting Cells | 5 | 2023 | 367 | 1.010 |
Why?
| | Pluripotent Stem Cells | 2 | 2022 | 77 | 0.920 |
Why?
| | Pancreatitis, Chronic | 1 | 2024 | 51 | 0.870 |
Why?
| | Transplantation, Autologous | 1 | 2024 | 211 | 0.850 |
Why?
| | Pancreatectomy | 1 | 2024 | 241 | 0.760 |
Why?
| | Blood Glucose | 6 | 2024 | 2097 | 0.750 |
Why?
| | Insulin | 5 | 2024 | 2326 | 0.650 |
Why?
| | Polymorphism, Single Nucleotide | 4 | 2025 | 2073 | 0.620 |
Why?
| | Diabetes Mellitus | 2 | 2021 | 1001 | 0.570 |
Why?
| | Twins, Dizygotic | 1 | 2018 | 181 | 0.570 |
Why?
| | Twins, Monozygotic | 1 | 2018 | 210 | 0.560 |
Why?
| | Hypoglycemic Agents | 3 | 2024 | 1220 | 0.550 |
Why?
| | Autoantibodies | 8 | 2025 | 1466 | 0.540 |
Why?
| | Stem Cells | 1 | 2021 | 577 | 0.520 |
Why?
| | Addison Disease | 3 | 2011 | 43 | 0.500 |
Why?
| | Glucose Tolerance Test | 3 | 2025 | 356 | 0.490 |
Why?
| | Autoimmunity | 3 | 2023 | 862 | 0.490 |
Why?
| | Islets of Langerhans | 2 | 2018 | 791 | 0.430 |
Why?
| | Steroid 21-Hydroxylase | 2 | 2011 | 30 | 0.420 |
Why?
| | Quality of Life | 1 | 2024 | 2704 | 0.400 |
Why?
| | Pancreas | 3 | 2024 | 306 | 0.350 |
Why?
| | Embryonic Stem Cells | 2 | 2021 | 118 | 0.340 |
Why?
| | Glutamate Decarboxylase | 2 | 2022 | 166 | 0.330 |
Why?
| | Child | 9 | 2025 | 20883 | 0.330 |
Why?
| | Adolescent | 8 | 2025 | 20393 | 0.330 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2009 | 200 | 0.290 |
Why?
| | Autoimmune Diseases | 2 | 2011 | 426 | 0.290 |
Why?
| | Young Adult | 5 | 2025 | 12426 | 0.280 |
Why?
| | HLA-DR3 Antigen | 2 | 2022 | 80 | 0.280 |
Why?
| | Genetic Predisposition to Disease | 4 | 2025 | 2282 | 0.270 |
Why?
| | Polymorphism, Genetic | 1 | 2009 | 640 | 0.260 |
Why?
| | Child, Preschool | 4 | 2024 | 10517 | 0.240 |
Why?
| | Family | 2 | 2025 | 657 | 0.230 |
Why?
| | Cell Differentiation | 2 | 2022 | 1902 | 0.220 |
Why?
| | Humans | 21 | 2025 | 129650 | 0.220 |
Why?
| | Adult | 9 | 2025 | 35576 | 0.210 |
Why?
| | Haplotypes | 3 | 2022 | 475 | 0.210 |
Why?
| | Genetic Association Studies | 1 | 2025 | 360 | 0.210 |
Why?
| | Protein Tyrosine Phosphatase, Non-Receptor Type 2 | 1 | 2022 | 11 | 0.200 |
Why?
| | Male | 10 | 2025 | 63681 | 0.200 |
Why?
| | Insulins | 1 | 2023 | 37 | 0.200 |
Why?
| | Administration, Oral | 1 | 2024 | 786 | 0.190 |
Why?
| | Female | 10 | 2025 | 68776 | 0.190 |
Why?
| | HLA-DR4 Antigen | 1 | 2022 | 78 | 0.190 |
Why?
| | Induced Pluripotent Stem Cells | 2 | 2021 | 221 | 0.190 |
Why?
| | Insulin Antibodies | 1 | 2022 | 105 | 0.180 |
Why?
| | Adenosine Triphosphatases | 1 | 2021 | 161 | 0.170 |
Why?
| | HLA Antigens | 1 | 2022 | 234 | 0.170 |
Why?
| | Neuronal Outgrowth | 1 | 2020 | 8 | 0.170 |
Why?
| | Risk | 2 | 2021 | 854 | 0.170 |
Why?
| | Transplantation, Homologous | 1 | 2021 | 401 | 0.160 |
Why?
| | Immune System | 1 | 2021 | 175 | 0.160 |
Why?
| | Diabetic Neuropathies | 1 | 2020 | 96 | 0.160 |
Why?
| | Disease Progression | 3 | 2018 | 2635 | 0.150 |
Why?
| | Seroepidemiologic Studies | 1 | 2018 | 156 | 0.150 |
Why?
| | Motor Neurons | 1 | 2020 | 236 | 0.140 |
Why?
| | Siblings | 1 | 2018 | 215 | 0.140 |
Why?
| | Hyperglycemia | 1 | 2021 | 328 | 0.140 |
Why?
| | Retrospective Studies | 2 | 2025 | 14518 | 0.140 |
Why?
| | Diseases in Twins | 1 | 2018 | 176 | 0.140 |
Why?
| | Longitudinal Studies | 1 | 2024 | 2717 | 0.140 |
Why?
| | Risk Factors | 5 | 2024 | 9765 | 0.130 |
Why?
| | Mass Screening | 2 | 2018 | 1149 | 0.130 |
Why?
| | Twins | 1 | 2018 | 249 | 0.130 |
Why?
| | Environment | 1 | 2018 | 343 | 0.130 |
Why?
| | Hypoglycemia | 1 | 2021 | 427 | 0.130 |
Why?
| | Oxygen | 1 | 2020 | 915 | 0.120 |
Why?
| | T-Lymphocytes | 1 | 2022 | 1928 | 0.110 |
Why?
| | Magnetic Resonance Imaging | 2 | 2024 | 3408 | 0.100 |
Why?
| | Biomarkers | 1 | 2024 | 3973 | 0.100 |
Why?
| | HLA-DQ Antigens | 2 | 2009 | 179 | 0.090 |
Why?
| | HLA-DR Antigens | 2 | 2009 | 224 | 0.090 |
Why?
| | HLA-B Antigens | 1 | 2011 | 62 | 0.090 |
Why?
| | Endocrine Cells | 1 | 2010 | 7 | 0.090 |
Why?
| | Genotype | 3 | 2011 | 1839 | 0.090 |
Why?
| | Alleles | 2 | 2011 | 845 | 0.080 |
Why?
| | Treatment Outcome | 1 | 2024 | 10230 | 0.080 |
Why?
| | HLA-DQ beta-Chains | 1 | 2009 | 61 | 0.080 |
Why?
| | Graves Disease | 1 | 2009 | 35 | 0.080 |
Why?
| | Nuclear Family | 1 | 2009 | 51 | 0.080 |
Why?
| | Homozygote | 1 | 2009 | 193 | 0.080 |
Why?
| | HLA-DRB1 Chains | 1 | 2009 | 108 | 0.080 |
Why?
| | Insulin Infusion Systems | 2 | 2023 | 363 | 0.080 |
Why?
| | Microsatellite Repeats | 1 | 2009 | 164 | 0.080 |
Why?
| | HLA-D Antigens | 1 | 2008 | 34 | 0.070 |
Why?
| | Interferon-alpha | 1 | 2009 | 194 | 0.070 |
Why?
| | Reference Values | 1 | 2009 | 793 | 0.070 |
Why?
| | Blood Glucose Self-Monitoring | 2 | 2023 | 601 | 0.070 |
Why?
| | Polymerase Chain Reaction | 1 | 2009 | 1038 | 0.070 |
Why?
| | Insulin Resistance | 1 | 2013 | 1165 | 0.060 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2009 | 1368 | 0.050 |
Why?
| | Technology | 1 | 2023 | 86 | 0.050 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2021 | 97 | 0.040 |
Why?
| | Prospective Studies | 2 | 2024 | 7133 | 0.040 |
Why?
| | Healthy Volunteers | 1 | 2021 | 200 | 0.040 |
Why?
| | Phantoms, Imaging | 1 | 2021 | 137 | 0.040 |
Why?
| | DNA, Mitochondrial | 1 | 2021 | 191 | 0.040 |
Why?
| | Cell Hypoxia | 1 | 2020 | 235 | 0.040 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2013 | 2441 | 0.040 |
Why?
| | Cross-Sectional Studies | 1 | 2009 | 5066 | 0.040 |
Why?
| | Gene Frequency | 2 | 2010 | 503 | 0.040 |
Why?
| | Mitochondrial Proteins | 1 | 2020 | 248 | 0.040 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2021 | 744 | 0.030 |
Why?
| | Action Potentials | 1 | 2020 | 486 | 0.030 |
Why?
| | Transcriptome | 1 | 2021 | 887 | 0.030 |
Why?
| | Calcium | 1 | 2021 | 1213 | 0.030 |
Why?
| | Cell Line | 1 | 2020 | 2781 | 0.030 |
Why?
| | Mitochondria | 1 | 2020 | 877 | 0.030 |
Why?
| | Reproducibility of Results | 1 | 2021 | 3083 | 0.030 |
Why?
| | RNA, Messenger | 1 | 2020 | 2708 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2020 | 4083 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2021 | 2548 | 0.020 |
Why?
| | HLA-B15 Antigen | 1 | 2011 | 13 | 0.020 |
Why?
| | HLA-B8 Antigen | 1 | 2010 | 14 | 0.020 |
Why?
| | Life Style | 1 | 2013 | 460 | 0.020 |
Why?
| | Linkage Disequilibrium | 1 | 2010 | 257 | 0.020 |
Why?
| | DNA Mutational Analysis | 1 | 2010 | 387 | 0.020 |
Why?
| | Pedigree | 1 | 2010 | 487 | 0.020 |
Why?
| | Middle Aged | 1 | 2009 | 31154 | 0.020 |
Why?
|
|
Triolo's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|